Compare VSAT & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VSAT | BIO |
|---|---|---|
| Founded | 1986 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 8.0B |
| IPO Year | 1996 | 1994 |
| Metric | VSAT | BIO |
|---|---|---|
| Price | $70.61 | $378.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 4 |
| Target Price | $59.80 | ★ $339.75 |
| AVG Volume (30 Days) | ★ 1.5M | 233.4K |
| Earning Date | 05-19-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 94.42 | ★ 142.61 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,583,200,000.00 |
| Revenue This Year | $5.32 | $2.74 |
| Revenue Next Year | $3.57 | $3.20 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 0.65 |
| 52 Week Low | $26.10 | $236.73 |
| 52 Week High | $93.03 | $396.23 |
| Indicator | VSAT | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 46.10 | 51.13 |
| Support Level | $66.99 | $284.88 |
| Resistance Level | $75.57 | $396.23 |
| Average True Range (ATR) | 3.82 | 9.70 |
| MACD | 0.18 | -4.42 |
| Stochastic Oscillator | 42.97 | 13.01 |
Viasat Inc an world-wide provider of communications technologies and services, focused on making connectivity accessible, available and secure for current and future customers world-wide. The company has two reportable segments: communication services and defense and advanced technologies. It generates majority of revenue from communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers. It has presence in United States and Outside United States. The company generates majority of revenue from United States. Its products are Antennas, Terminals & radios, Modems, Semiconductors, Cybersecurity, Software & services, Home internet.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.